A fibroblast growth factor 21 (FGF21) variant, further to a FGF21 variant fusion protein, a protein multimer, and use thereof are provided. The FGF21 variant, fusion protein and protein multimer can significantly improve the binding ability with the target and can be used to treat metabolic diseases.